Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, UK perspective. (2022)
Attributed to:
Experimental Medicine INitiative to Explore New Therapies - Phase 2
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keac061
PubMed Identifier: 35104331
Publication URI: http://europepmc.org/abstract/MED/35104331
Type: Journal Article/Review
Volume: 61
Parent Publication: Rheumatology (Oxford, England)
Issue: 5
ISSN: 1462-0324